Company Filing History:
Years Active: 2019-2022
Title: Martin Westphal: Innovator in Cancer Treatment
Introduction
Martin Westphal is a notable inventor based in Bad Homburg, Germany. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, Westphal's work focuses on enhancing the efficacy of anticancer agents.
Latest Patents
Westphal's latest patents include a composition comprising EPA and DHA for an enhanced efficacy of anticancer agents. This invention relates to the enhancement of anticancer agents by utilizing a composition that includes an aqueous phase, an oil phase, EPA, and DHA for the treatment of solid tumors. The composition is designed to contain EPA and DHA in specific weight ratios, ensuring optimal effectiveness in conjunction with anticancer agents. Another significant patent is for hydroxyalkyl starch for the treatment of hematological neoplasms. This invention involves a pharmaceutical preparation that effectively reduces the proliferation rate of cancer cells and inhibits their growth, utilizing hydroxyalkyl starch with specific molecular weight and molar substitution characteristics.
Career Highlights
Westphal is currently employed at Fresenius Kabi Deutschland GmbH, where he continues to develop innovative solutions in the medical field. His work is instrumental in advancing cancer treatment methodologies.
Collaborations
Some of his notable coworkers include Silke Baasner and Edmundo Brito De La Fuente, who contribute to the collaborative efforts in research and development at Fresenius Kabi.
Conclusion
Martin Westphal's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to influence the medical field positively.